| Dr David E Pittenger, MD | |
|
557 N Washington St, Janesville, WI 53548-2907 | |
| (608) 754-6000 | |
| Not Available |
| Full Name | Dr David E Pittenger |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 557 N Washington St, Janesville, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023179066 | NPI | - | NPPES |
| 31718800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 31959 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health System Corp | Janesville, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health System Corporation | 7416860440 | 459 |
News Archive
Researchers at Henry Ford Hospital in Detroit have uncovered previously unidentified genes that may be responsible for keloid scarring, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment.
The Center for Global Development's (CGD) "Global Health Policy" blog on Thursday published two posts addressing family planning funding. In one, Amanda Glassman, director of global health policy and a research fellow at CGD, examines "what organization will actually allocate and spend these additional resources" pledged at the recent London Summit on Family Planning.
A Softer Place, LLC has announced the completion of Stage I of www.asofterplace.com. Refreshingly easy to use, straightforward, and timely, this Dallas-based website is the ultimate in online local advertising. It brings together only the very best senior care facilities, professionals and service providers in the area, in one comprehensive and informative directory; a "go to" place, where those who need help can find it quickly and easily with "two clicks" of the mouse.
The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 9 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031113000164 |
News Archive
Researchers at Henry Ford Hospital in Detroit have uncovered previously unidentified genes that may be responsible for keloid scarring, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment.
The Center for Global Development's (CGD) "Global Health Policy" blog on Thursday published two posts addressing family planning funding. In one, Amanda Glassman, director of global health policy and a research fellow at CGD, examines "what organization will actually allocate and spend these additional resources" pledged at the recent London Summit on Family Planning.
A Softer Place, LLC has announced the completion of Stage I of www.asofterplace.com. Refreshingly easy to use, straightforward, and timely, this Dallas-based website is the ultimate in online local advertising. It brings together only the very best senior care facilities, professionals and service providers in the area, in one comprehensive and informative directory; a "go to" place, where those who need help can find it quickly and easily with "two clicks" of the mouse.
The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David E Pittenger, MD 557 N Washington St, Janesville, WI 53548-2907 Ph: (608) 754-6000 | Dr David E Pittenger, MD 557 N Washington St, Janesville, WI 53548-2907 Ph: (608) 754-6000 |
News Archive
Researchers at Henry Ford Hospital in Detroit have uncovered previously unidentified genes that may be responsible for keloid scarring, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment.
The Center for Global Development's (CGD) "Global Health Policy" blog on Thursday published two posts addressing family planning funding. In one, Amanda Glassman, director of global health policy and a research fellow at CGD, examines "what organization will actually allocate and spend these additional resources" pledged at the recent London Summit on Family Planning.
A Softer Place, LLC has announced the completion of Stage I of www.asofterplace.com. Refreshingly easy to use, straightforward, and timely, this Dallas-based website is the ultimate in online local advertising. It brings together only the very best senior care facilities, professionals and service providers in the area, in one comprehensive and informative directory; a "go to" place, where those who need help can find it quickly and easily with "two clicks" of the mouse.
The U.S. Food and Drug Administration has approved the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 9 days ago
Dr. Harlan D Edelman, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 | |
Dr. Pinak Y Shukla, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 | |
Brian J Keyes, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8931 | |
Douglas R Palmer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 | |
Dr. Sidney Schulman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 | |
Ellen M Obrien, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5026 N Northwood Trce, Janesville, WI 53545 Phone: 608-295-9500 |